Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

How Pernix Therapeutics Holdings Inc (PTX) Stacks Up Against Its Peers

Page 1 of 2

Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential small-cap stocks and pouring cash into these candidates. Small-cap stocks are overlooked by most investors, brokerage houses, and financial services hubs, while the unlimited research abilities of the big players within the hedge fund industry can easily identify the undervalued and high-potential stocks that reside the ignored corners of equity markets. There are numerous small-cap stocks that have turned out to be great winners, which is one of the main reasons the Insider Monkey team pays close attention to the hedge fund activity in relation to these stocks.

Pernix Therapeutics Holdings Inc (NASDAQ:PTX) shareholders have witnessed a decrease in hedge fund interest recently. There were 10 hedge funds in our database with PTX positions at the end of the second quarter, which fell by 4 during the third quarter. At the end of this article we will also compare PTX to other stocks including Hudson Global Inc (NASDAQ:HSON), Concurrent Computer Corp (NASDAQ:CCUR), and Lincoln Educational Services Corporation (NASDAQ:LINC) to get a better sense of its popularity.

Follow Pernix Therapeutics Holdings Inc. (NASDAQ:PTX)
Trade (NASDAQ:PTX) Now!

We care about hedge fund sentiment because historically hedge funds’ stock picks delivered strong risk adjusted returns. There are certain segments of the market where hedge funds’ stock picks performed much better than its benchmarks. For instance, the 30 most popular mid-cap stocks among the best performing hedge funds returned 18% over the last 12 months outpacing S&P 500 Index by more than 10 percentage points. We developed this strategy 2.5 years ago and started sharing its picks in our quarterly newsletter. It bested the S&P 500 Index ETFs by delivering a solid 39% vs. 22% gain for its benchmarks.

Image Point Fr/Shutterstock.com

Image Point Fr/Shutterstock.com

How have hedgies been trading Pernix Therapeutics Holdings Inc (NASDAQ:PTX)?

At Q3’s end, a total of 6 of the hedge funds tracked by Insider Monkey were bullish on this stock, a 40% fall from the previous quarter. On the other hand, there were a total of 17 hedge funds with a bullish position in PTX a year earlier, so hedge fund sentiment has fallen significantly. So, let’s find out which hedge funds remain among the top holders of the stock and which hedge funds were making big moves.

ptx

According to Insider Monkey’s hedge fund database, Broadfin Capital, led by Kevin Kotler, holds the most valuable position in Pernix Therapeutics Holdings Inc (NASDAQ:PTX). Broadfin Capital has a $4.3 million position in the stock. The second most bullish fund manager is Renaissance Technologies, one of the largest hedge funds in the world, which holds a $3 million position. Other peers with similar optimism comprise Dennis Purcell’s Aisling Capital, Samuel Isaly’s OrbiMed Advisors, and Ken Griffin’s Citadel Investment Group. We should note that none of these hedge funds are among our list of the 100 best performing hedge funds, which is based on the performance of their 13F long positions in non-micro-cap stocks.

Page 1 of 2